ICON Forms Clinical Development Partnership with Mereo BioPharma
Contract research organization ICON plc announced a partnership with Mereo BioPharma Group, a specialty biopharmaceutical company.
Contract research organization ICON plc announced a partnership with Mereo BioPharma Group, a specialty biopharmaceutical company. Under this partnership, ICON will be the sole provider of clinical development services to Mereo.
Mereo is a new UK company that is focused on acquiring, developing and commercializing medicines that are targeted at rare and specialist disease areas. The company’s initial portfolio consists of clinical-stage products acquired from Novartis and are targeted at brittle bone syndrome, acute exacerbations of chronic obstructive pulmonary disease and hypogonadotropic hypogonadism.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
